Gene-specific therapy for inherited arrhythmogenic diseases

Pharmacology and Therapeutics

Volumn 110, Issue 1, 2006, Pages 1-13

  Napolitano, Carlo ^a   Bloise, Raffaella ^a   Priori, Silvia G ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cardiac arrhythmias; Gene specific therapy; Genetic; Genotype phenotype correlation; Sudden death

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; 4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; ASTEMIZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CISAPRIDE; DILTIAZEM; FEXOFENADINE; FLECAINIDE; LIDOCAINE; MEXILETINE; QUINIDINE; RYANODINE RECEPTOR; TEDISAMIL; TERFENADINE; THAPSIGARGIN;

BRUGADA SYNDROME; DEFIBRILLATOR; DRUG MECHANISM; DRUG MEGADOSE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLYCOGEN STORAGE DISEASE TYPE 4; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; SICK SINUS SYNDROME; TIMOTHY SYNDROME;

ANIMALS; ARRHYTHMIA; GENE THERAPY; HUMANS;

EID: 32644478038     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.08.003     Document Type: Review

References (86)

1. G.W. Abbott, F. Sesti, I. Splawski, M.E. Buck, M.H. Lehmann, and K.W. Timothy MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia Cell 97 1999 175 187
2. H. Abriel, X.H. Wehrens, J. Benhorin, B. Kerem, and R.S. Kass Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome Circulation 102 2000 921 925
3. H. Abriel, C. Cabo, X.H. Wehrens, I. Rivolta, H.K. Motoike, and M. Memmi Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel Circ Res 88 2001 740 745
4. R.H. An, X.L. Wang, B. Kerem, J. Benhorin, A. Medina, and M. Goldmit Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits Circ Res 83 1998 141 146
5. E.D. Andersen, P.A. Krasilnikoff, and H. Overvad Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand 60 1971 559 564
6. C. Antzelevitch The Brugada syndrome: ionic basis and arrhythmia mechanisms J Cardiovasc Electrophysiol 12 2001 268 272
7. J. Barhanin, F. Lesage, E. Guillemare, M. Fink, M. Lazdunski, and G. Romey K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current Nature 384 1996 78 80
8. G. Baroudi, V. Pouliot, I. Denjoy, P. Guicheney, A. Shrier, and M. Chahine Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G) Circ Res 88 2001 E78 E83
9. B. Belhassen, S. Viskin, R. Fish, A. Glick, I. Setbon, and M. Eldar Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome J Cardiovasc Electrophysiol 10 1999 1301 1312
10. B. Belhassen, A. Glick, and S. Viskin Efficacy of quinidine in high-risk patients with Brugada syndrome Circulation 110 2004 1731 1737
11. C. Bellocq, A.C. van Ginneken, C.R. Bezzina, M. Alders, D. Escande, and M.M. Mannens Mutation in the KCNQ1 gene leading to the short QT-interval syndrome Circulation 109 2004 2394 2397
12. P.B. Bennett, K. Yazawa, N. Makita, and A.L. George Jr. Molecular mechanism for an inherited cardiac arrhythmia Nature 376 1995 683 685
13. P. Bjerregaard, and I. Gussak Short QT syndrome: mechanisms, diagnosis and treatment Nat Clin Pract 2 2 2005 84 87
14. P. Brugada, and J. Brugada Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report J Am Coll Cardiol 20 1992 1391 1396
15. R. Brugada, K. Hong, R. Dumaine, J. Cordeiro, F. Gaita, and M. Borggrefe Sudden death associated with short-QT syndrome linked to mutations in HERG Circulation 109 2004 30 35
16. M. Cerrone, B. Colombi, M. Santoro, M. Raffale di Barletta, M. Scelsi, and L. Villani Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor (RyR2) Circ Res 96 2005 e77 e82
17. Q. Chen, G.E. Kirsch, D. Zhang, R. Brugada, J. Brugada, and P. Brugada Genetic basis and molecular mechanism for idiopathic ventricular fibrillation Nature 392 1998 293 296
18. Y.H. Chen, S.J. Xu, S. Bendahhou, X.L. Wang, Y. Wang, and W.Y. Xu KCNQ1 gain-of-function mutation in familial atrial fibrillation Science 299 2003 251 254
19. S.J. Compton, R.L. Lux, M.R. Ramsey, K.R. Strelich, M.C. Sanguinetti, and L.S. Green Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium Circulation 94 1996 1018 1022
20. P. Coumel, J. Fidelle, V. Lucet, P. Attuel, and Y. Bouvrain Catecholaminergic-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases Br Heart J 40 1978 28 37
21. B.P. Delisle, C.L. Anderson, R.C. Balijepalli, B.D. Anson, T.J. Kamp, and C.T. January Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C J Biol Chem 278 2003 35749 35754
22. M.R. Donaldson, G. Yoon, Y.H. Fu, and L.J. Ptacek Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity Ann Med 36 Suppl. 1, 92-7 2004 92 97
23. L. Eckardt, H.J. Bruns, M. Paul, P. Kirchhof, E. Schulze-Bahr, and T. Wichter Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome J Cardiovasc Electrophysiol 13 2002 742 749
24. H. Fodstad, H. Swan, M. Auberson, I. Gautschi, J. Loffing, and L. Schild Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome J Mol Cell Cardiol 37 2004 593 602
25. B. Freestone, and G.Y. Lip Tedisamil: a new novel antiarrhythmic Expert Opin Investig Drugs 13 2004 151 160
26. F. Gaita, C. Giustetto, F. Bianchi, C. Wolpert, R. Schimpf, and R. Riccardi Short QT syndrome: a familial cause of sudden death Circulation 108 2003 965 970
27. F. Gaita, C. Giustetto, F. Bianchi, R. Schimpf, M. Haissaguerre, and L. Calo Short QT syndrome: pharmacological treatment J Am Coll Cardiol 43 2004 1494 1499
28. L. Gouas, C. Bellocq, M. Berthet, F. Potet, S. Demolombe, and A. Forhan New KCNQ1 mutations leading to haploinsufficiency in a general population; defective trafficking of a KvLQT1 mutant Cardiovasc Res 63 2004 60 68
29. I. Gussak, P. Brugada, J. Brugada, R.S. Wright, S.L. Kopecky, and B.R. Chaitman Idiopathic short QT interval: a new clinical syndrome? Cardiology 94 2000 99 102
30. J.S. Hermida, I. Denjoy, J. Clerc, F. Extramiana, G. Jarry, and P. Milliez Hydroquinidine therapy in Brugada syndrome J Am Coll Cardiol 43 2004 1853 1860
31. D. Jiang, B. Xiao, L. Zhang, and S.R. Chen Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death Circ Res 91 2002 218 225
32. A.M. Joseph-Reynolds, S.M. Auden, and W.L. Sobczyzk Perioperative considerations in a newly described subtype of congenital long QT syndrome Paediatr Anaesth 7 1997 237 241
33. H.G. Kehl, W. Haverkamp, G. Rellensmann, T.M. Yelbuz, T. Krasemann, and J. Vogt Images in cardiovascular medicine. Life-threatening neonatal arrhythmia: successful treatment and confirmation of clinically suspected extreme long QT-syndrome-3 Circulation 109 2004 e205 e206
34. S. Kupershmidt, T. Yang, and D.M. Roden Modulation of cardiac Na+ current phenotype by beta1-subunit expression Circ Res 83 1998 441 447
35. A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D.D. Ngoc, and P. Coumel Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients Circulation 91 1995 1512 1519
36. S.E. Lehnart, X.H. Wehrens, and A.R. Marks Calstabin deficiency, ryanodine receptors, and sudden cardiac death Biochem Biophys Res Commun 322 2004 1267 1279
37. S.E. Lehnart, X.H.T. Wehrens, P.J. Laitinen, S.R. Reiken, S.X. Deng, and Z. Cheng Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak Circulation 109 2004 3208 3214
38. S.E. Levin Long QT syndrome associated with syndactyly in a female Am J Cardiol 78 1996 380
39. M.L. Marks, D.L. Trippel, and M.T. Keating Long QT syndrome associated with syndactyly identified in females Am J Cardiol 76 1995 744 745
40. M.L. Marks, S.L. Whisler, C. Clericuzio, and M. Keating A new form of long QT syndrome associated with syndactyly J Am Coll Cardiol 25 1995 59 64
41. A.R. Marks, S. Priori, M. Memmi, K. Kontula, and P.J. Laitinen Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia J Cell Physiol 190 2002 1 6
42. K. Matsuo, T. Kurita, M. Inagaki, M. Kakishita, N. Aihara, and W. Shimizu The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome Eur Heart J 20 1999 465 470
43. A.J. Moss, W. Zareba, J. Benhorin, E.H. Locati, W.J. Hall, and J.L. Robinson ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome Circulation 92 1995 2929 2934
44. C. Napolitano, R. Bloise, M. Lunati, M. Gasparini, C. Cavalli, and E. Cerini Prolongation of QT interval and syndactyly: characterization of a novel variant of the long QT syndrome Circulation 104 Suppl II 2001 365 (abstract)
45. N.M. Plaster, R. Tawil, M. Tristani-Firouzi, S. Canun, S. Bendahhou, and A. Tsunoda Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome Cell 105 2001 511 519
46. S.G. Priori, C. Napolitano, F. Cantu, A.M. Brown, and P.J. Schwartz Differential response to Na+ channel blockade, beta-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome Circ Res 78 1996 1009 1015
47. S.G. Priori, C. Napolitano, and P.J. Schwartz Low penetrance in the long-QT syndrome: clinical impact Circulation 99 1999 529 533
48. S.G. Priori, C. Napolitano, P.J. Schwartz, R. Bloise, L. Crotti, and E. Ronchetti The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge Circulation 102 2000 945 947
49. S.G. Priori, C. Napolitano, N. Tiso, M. Memmi, G. Vignati, and R. Bloise Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
50. S.G. Priori, C. Napolitano, M. Memmi, B. Colombi, F. Drago, and M. Gasparini Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia Circulation 106 2002 69 74
51. S.G. Priori, I. Rivolta, and C. Napolitano Genetics of long QT, Brugada and other channellopathies D.P. Zipes J. Jalife Cardiac Electrophysiology 4th ed 2003 Elsevier Philadelphia 462 470
52. S.G. Priori, P.J. Schwartz, C. Napolitano, R. Bloise, E. Ronchetti, and M. Grillo Risk stratification in the long-QT syndrome N Engl J Med 348 2003 1866 1874
53. S.G. Priori, C. Napolitano, and P.J. Schwartz Genetics of cardiac arrhythmias D.P. Zipes P. Libby R.O. Bonow E. Braunwald Braunwald's Heart Disease 2004 Elsevier Philadelphia 689 695
54. S.G. Priori, C. Napolitano, P.J. Schwartz, M. Grillo, R. Bloise, and E. Ronchetti Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers JAMA 292 2004 1341 1344
55. S.G. Priori, I. Rivolta, and C. Napolitano Genetic of long QT, Brugada, and other channellopathies D.P. Zipes J. Jalife Cardiac Electrophysiology. From Cell to Bedside 2004 Saunders Philadelphia 462 470
56. S.G. Priori, S.V. Pandit, I. Rivolta, O. Berenfeld, E. Ronchetti, and A. Dhamoon A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene Circ Res 96 2005 800 807
57. S. Rajamani, C.L. Anderson, B.D. Anson, and C.T. January Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block Circulation 105 2002 2830 2835
58. I. Rivolta, H. Abriel, M. Tateyama, H. Liu, M. Memmi, and P. Vardas Inherited Brugada and LQT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes J Biol Chem 276 2001 30623 30630
59. I. Rivolta, E. Giarda, J. Nastoli, E. Ronchetti, C. Napolitano, and S.G. Priori In vitro characterization of the electrophysiological eefects of mexiletine on SCN5A mutants predicts clinical response in LQT3 patients Circulation 110 17 2004 III-230 (abstract)
60. M.C. Sanguinetti, and N.K. Jurkiewicz Delayed rectifier outward K+ current is composed of two currents in guinea pig atrial cells Am J Physiol 260 1991 H393 H399
61. J.J. Schott, C. Alshinawi, F. Kyndt, V. Probst, T.M. Hoorntje, and M. Hulsbeek Cardiac conduction defects associate with mutations in SCN5A Nat Genet 23 1999 20 21
62. P.J. Schwartz, S.G. Priori, E.H. Locati, C. Napolitano, F. Cantu, and J.A. Towbin Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy Circulation 92 1995 3381 3386
63. P.J. Schwartz, S.G. Priori, R. Dumaine, C. Napolitano, C. Antzelevitch, and M. Stramba-Badiale A molecular link between the sudden infant death syndrome and the long-QT syndrome N Engl J Med 343 2000 262 267
64. P.J. Schwartz, S.G. Priori, C. Spazzolini, A.J. Moss, G.M. Vincent, and C. Napolitano Genotype-phenotype correlation in the long-QT syndrome : gene-specific triggers for life-threatening arrhythmias Circulation 103 2001 89 95
65. F. Sesti, G.W. Abbott, J. Wei, K.T. Murray, S. Saksena, and P.J. Schwartz A common polymorphism associated with antibiotic-induced cardiac arrhythmia Proc Natl Acad Sci U S A 97 2000 10613 10618
66. I. Splawski, M. Tristani-Firouzi, M.H. Lehmann, M.C. Sanguinetti, and M.T. Keating Mutations in the hminK gene cause long QT syndrome and suppress IKs function Nat Genet 17 1997 338 340
67. I. Splawski, J. Shen, K.W. Timothy, M.H. Lehmann, S. Priori, and J.L. Robinson Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Circulation 102 2000 1178 1185
68. I. Splawski, K.W. Timothy, L.M. Sharpe, N. Decher, P. Kumar, and R. Bloise Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31
69. H. Swan, K. Piippo, M. Viitasalo, P. Heikkila, T. Paavonen, and K. Kainulainen Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts J Am Coll Cardiol 34 1999 2035 2042
70. R. Tawil, L.J. Ptacek, S.G. Pavlakis, D.C. DeVivo, A.S. Penn, and C. Ozdemir Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features Ann Neurol 35 1994 326 330
71. D.J. Tester, M.L. Will, C.M. Haglund, and M.J. Ackerman Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing Heart Rhythm 2 2005 507 517
72. M. Tristani-Firouzi, J.L. Jensen, M.R. Donaldson, V. Sansone, G. Meola, and A. Hahn Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) J Clin Invest 110 2002 381 388
73. T. Tsuchiya, K. Ashikaga, T. Honda, and M. Arita Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome J Cardiovasc Electrophysiol 13 2002 698 701
74. C.R. Valdivia, M.J. Ackerman, D.J. Tester, T. Wada, J. McCormack, and B. Ye A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine Cardiovasc Res 55 2002 279 289
75. C.R. Valdivia, D.J. Tester, B.A. Rok, C.B. Porter, T.M. Munger, and A. Jahangir A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs Cardiovasc Res 62 2004 53 62
76. S. Viatchenko-Karpinski, D. Terentyev, I. Gyorke, R. Terentyeva, P. Volpe, and S.G. Priori Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin Circ Res 94 2004 471 477
77. Q. Wang, J. Shen, I. Splawski, D. Atkinson, Z. Li, and J.L. Robinson SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome Cell 80 1995 805 811
78. D.W. Wang, K. Yazawa, A.L. George Jr., and P.B. Bennett Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome Proc Natl Acad Sci U S A 93 1996 13200 13205
79. X.H. Wehrens, S.E. Lehnart, F. Huang, J.A. Vest, S.R. Reiken, and P.J. Mohler FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death Cell 113 2003 829 840
80. X.H. Wehrens, S.E. Lehnart, S.R. Reiken, S.X. Deng, J.A. Vest, and D. Cervantes Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2 Science 304 2004 292 296
81. L. Wolff Familial auricular fibrillation N Engl J Med 229 1943 396 397
82. G.X. Yan, and C. Antzelevitch Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation Circulation 100 1999 1660 1666
83. G. Yang, M. Xia, Q. Jin, S. Benedahhou, J. Shi, and J. Chen Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation Am J Hum Genet 75 2004 899 905
84. M. Yano, S. Kobayashi, M. Kohno, M. Doi, T. Tokuhisa, and S. Okuda FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure Circulation 107 2003 477 484
85. Z. Zhou, Q. Gong, M.L. Epstein, and C.T. January HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects J Biol Chem 273 1998 21061 21066
86. Z. Zhou, Q. Gong, and C.T. January Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects J Biol Chem 274 1999 31123 31126